| 配分額 *注記 |
4,680千円 (直接経費: 3,600千円、間接経費: 1,080千円)
2027年度: 910千円 (直接経費: 700千円、間接経費: 210千円)
2026年度: 2,340千円 (直接経費: 1,800千円、間接経費: 540千円)
2025年度: 1,430千円 (直接経費: 1,100千円、間接経費: 330千円)
|
|---|
| 研究開始時の研究の概要 |
We aim to recreate primate cardiovascular development in vitro using NHP cells to model fetal heart failure and embryonic diseases. By identifying species-specific markers with scRNA-seq, we enhance our understanding of cardiovascular morphogenesis and evolution. This ethically designed model opens new avenues for regenerative medicine, disease modelling, and complex synthetic embryo systems.
|
